Anne has been Managing Partner of MC Services since 2011 and has over 25 years of experience in Financial and Strategic Communications. She was instrumental in growing MC Services to a team of 40 people and a highly sustainable client roster. Anne established the office in Düsseldorf, building the team and operations there. Prior to joining the agency, she held senior management positions in international pharma and biotech companies. She headed Investor Relations and Corporate Communications at Evotec AG for 10 years and was a member of the company’s Executive Committee. During that time, she managed Evotec’s IPO on the Frankfurt Stock Exchange and Nasdaq, multiple M&A programs and major financial transactions. Previously, she was responsible for Investor Relations and Corporate Communications at Schwarz Pharma AG, where she initially held management positions in the International Marketing department. Anne is a pharmacist and marketing expert by training.
Raimund founded MC Services in 1999. Under his leadership, MC Services has grown to a team of 40 people with sites in Munich, Düsseldorf, Berlin, London and Boston. Prior to that, Raimund held senior management positions in international communications agencies where he was responsible for Business to Business, Corporate and Financial Communications. He has over 40 years of experience in Marketing and Communications and more than 20 years in Investor Relations. He has advised on IPOs in Germany, Belgium and the UK as well as on major international M&A and financial transactions. Raimund also advises companies on issues and crisis management. Raimund studied law, history and political science (MA).
Katja joined MC Services in 2013 and heads the Munich office as Managing Director. She is an expert in financial and strategic communications and a Certified Investor Relations Officer (CIRO). Katja has worked over 20 years for companies in biotech, medical technology, diagnostics and healthcare, as well as venture capital and other industries.
Before joining MC Services, she was Director of Corporate Communications & IR at WILEX (today Heidelberg Pharma), a listed oncology-focused biopharmaceutical company. She was responsible for the communication of a broad late-stage clinical pipeline and actively supported several financing and M&A transactions. Prior to that, she worked as a Senior Consultant with the financial communications agency CAT Consultants and as an external IR manager for doll maker Zapf Creation. Katja began her career at the healthcare and nursing home company, Marseille Kliniken, in the staff unit of the Executive Board. During her Business Administration studies at the Technical University of Dresden, she worked for several years as a freelancer for the contract management department at the German Privatization Agency (Treuhandanstalt).
Andreas joined MC Services in 2013. Dedicated to the Life Sciences industry, he has spent more than 30 years holding various senior management positions in international investment banking groups. During this time Andreas has built a comprehensive, high-profile network of international investors and sector experts.
He has successfully executed more than 100 international transactions. At WestLB AG he was jointly responsible for establishing the bank as one of the leading players in the healthcare financial markets. Prior to this, he worked for Deutsche Apotheker- und Aerztebank for over 7 years, where he built-up Life Sciences Research and tailored the concept of a well-established innovative healthcare fund.
In 2000 he also created and managed the launch of the first independent index for the European biotech industry “WestLB EU-Biotech Index Top20”.
Eva joined MC Services in 2018 and has more than 20 years of experience in Public Relations. Prior to joining MC Services, Eva worked with Ketchum Pleon, a global PR agency, for 14 years, where she played a leading role as a Business Director in the Company’s Healthcare department. She also previously worked at Fleishman-Hillard, serving clients from the pharmaceutical and insurance industries. Her experience includes working with several top 20 pharmaceutical companies, including in the areas of cardiology, diabetes, gastrointestinal diseases, pain, vaccines, and nutritional supplements (OTC). Eva holds a degree in law. In addition to corporate communications, Eva focuses on supporting clients’ commercialization activities, including the strategic positioning of new drugs and healthcare products. Tasks range from pre-approval market-shaping activities for potential prescribers to launch communications, as well as patient awareness, cross-marketing, crisis prevention and issues management.
Caro is Executive Director at MC Services. She joined the firm in 2011 and has taken on roles of increasing responsibility during her tenure. Clients rely on her strategic consulting, communications planning, crisis preparedness training and media relations skills. She is responsible for a wide range of accounts from large pharma to small biotech companies. Caro was instrumental in establishing the Düsseldorf office and building and developing the team. She studied English and journalism at the University of Leipzig, including a semester at the University of Wales in the UK. She also was a freelance writer for local newspapers and special interest magazines.
Shaun joined MC Services in 2009. He spent the last 20 years writing on and advising companies in the Life Sciences industry. Previously, he has been a director of Innovator Capital Limited, a boutique investment bank, and before this he was a director of Capital MS&L. Shaun focused on Public and Investor Relations for companies in the sector, advising on all aspects of their communications strategies. Prior to this, he spent over eight years as a reporter and later news editor and senior writer with BioCentury covering the global biotech and pharma industry. Shaun has written about and advised on major stories covering client companies and therapeutic subjects. Shaun is an IT specialist and economist by training. Besides his knowledge of the Life Sciences industry, Shaun’s sector expertise includes Renewable Energies, Cleantech and Economic Development. Shaun is FSA authorized.
Laurie joined MC Services in 2016 and has 25 years of investor relations and corporate communications experience. Prior to joining MC Services, Laurie led US IR and corporate communications at the French biotech, Transgene. She previously served as head of IR and corporate communications for immunotherapy company, Agennix, and led US IR and corporate communications for the oncology company, GPC Biotech. She began her IR career at Organogenesis, a tissue engineering firm. She has spearheaded a wide range of initiatives, including raising awareness and understanding of the companies for which she worked in the investment community and press. She has led IR and PR activities around a variety of major news events, including Phase III data readouts, M&A and leadership change, and has been a key team member for major financings, including a Nasdaq listing. Laurie has an MBA from Simmons University and a BA in Russian from Middlebury College.
Cora joined MC Services as Executive Director in 2023. Her focus lies on strategic international brand and corporate communication projects as well as business development. She combines her more than ten years of corporate communications expertise with a solid background in top-class international medical research settings. She started her career at London-based business communications consultancy Instinctif Partners to support their growing dedicated Life Sciences practice before joining MC Services for the first time in 2015 to focus on her passion: raising awareness for breakthrough science and building an image for growing innovative biotech’s via public and investor relations. She then moved to Rentschler Biopharma in 2019 as Senior Director Corporate Communication to lead all brand, marketing, and corporate communication activities as member of the Company’s global leadership team. A trained biotechnologist, Cora holds a PhD in neuroimmunology from the Max Planck Institute.
Solveigh joined MC Services in 2013 with over 14 years of experience in capital markets with a track-record of over 10 years as Director Investor Relations/Public Relations with QIAGEN, a global market leading company with dual-listings on the Deutsche Börse and NASDAQ exchanges. In this position, she was responsible for the company’s communications strategy during more than 20 M&A deals and numerous capital raising activities. Under her direction, the QIAGEN team was repeatedly awarded for its IR performance. Prior to joining QIAGEN, she worked as a sell-side analyst and life sciences sector specialist with former WestLB.